本页面由Tiger Trade Technology Pte. Ltd.提供服务

Inhibikase Therapeutics, Inc.

1.83
+0.13007.65%
盘后1.980.1500+8.20%19:59 EDT
成交量:162.03万
成交额:291.56万
市值:2.42亿
市盈率:-3.73
高:1.85
开:1.73
低:1.72
收:1.70
52周最高:2.37
52周最低:1.33
股本:1.32亿
流通股本:6,183.90万
量比:1.62
换手率:2.62%
股息:- -
股息率:- -
每股收益(TTM):-0.4909
每股收益(LYR):-0.3086
净资产收益率:-36.05%
总资产收益率:-20.53%
市净率:1.40
市盈率(LYR):-5.93

数据加载中...

2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/25

SEC问询函

Form CORRESP - Correspondence
2024/06/18

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/09

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/30

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/25

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/19

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/04/19

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/01

重要事件披露

Form 8-K - Current report
2024/01/16

重要事件披露

Form 8-K - Current report
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]